These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6905641)

  • 1. Impaired renal kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Stumpe KO; Overlack A; Ressel C; Krück F
    Agents Actions; 1980 Sep; 10(4):349-52. PubMed ID: 6905641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Kolloch R; Zywzok W; Krück F
    Klin Wochenschr; 1980 Jan; 58(1):37-42. PubMed ID: 6900133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low urinary kallikrein excretion and elevated blood pressure normalized by orally kallikrein in essential hypertension.
    Overlack A; Stumpe KO; Ressel C; Krück F
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():263s-265s. PubMed ID: 261517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral administration of extracted kallikrein to patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Ferri C; Luparini RL; Germanò G; Giarrizzo C; Santucci A; Balsano F
    Clin Ter; 1991 Oct 15-31; 139(1-2):3-8. PubMed ID: 1837764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein excretion and blood pressure response to angiotensin converting enzyme inhibitors and calcium antagonists in hypertensive patients.
    Dessì-Fulgheri P; Espinosa E; Zingaretti O; Guazzarotti F; Sarzani R; Pupita G; Sturbini S; Catalini R; Rappelli A
    J Hypertens; 1993 Jul; 11(7):725-30. PubMed ID: 8228191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and tolerance of orally administered kallikrein in patients with essential arterial hypertension].
    Bellini C; Carlomagno A; Piccoli A; Di Francesco L; Torregrossa G; Leonetti Luparini R; Germanò G; Giarrizzo C; Ferri C; Santucci A
    Ann Ital Med Int; 1991; 6(4):369-74. PubMed ID: 1804283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of the renal kallikrein-kinin system, intravascular volume, and renal hemodynamics to sodium restriction and diuretic treatment in essential hypertension.
    O'Connor DT
    Hypertension; 1982; 4(5 Pt 2):III72-8. PubMed ID: 7049933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kallikrein in hypertensive animal models.
    Keiser HR; Geller RG; Margolius HS; Pisano JJ
    Fed Proc; 1976 Feb; 35(2):199-202. PubMed ID: 1248654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary kallikrein excretion and sodium metabolism in hypertensive patients.
    Seino M; Abe K; Otsuka Y; Saito T; Irokawa N
    Tohoku J Exp Med; 1975 Aug; 116(4):359-367. PubMed ID: 1188919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function.
    O'Connor DT; Barg AP; Amend W; Vincenti F
    Am J Med; 1982 Oct; 73(4):475-81. PubMed ID: 6751083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
    Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
    Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study.
    Overlack A; Stumpe KO; Kolloch R; Ressel C; Krueck F
    Hypertension; 1981; 3(3 Pt 2):I18-21. PubMed ID: 7021412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of salt sensitivity on the blood pressure response to exogenous kallikrein in essential hypertensive patients.
    Bellini C; Ferri C; Piccoli A; Carlomagno A; Di Francesco L; Bonavita MS; Santucci A; Balsano F
    Nephron; 1993; 65(1):28-35. PubMed ID: 8413787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.